B
Bull
Bull · 25%MLSS
$0.99
Scenario price
$0.502
-0.003 (-0.59%)At close
Loading chart…
- High
- 0.512
- Open
- 0.494
- VWAP
- 0.50
- Vol
- 29.49K
- Mkt Cap
- 52.51M
- Low
- 0.493
- Amount
- 14.81K
- EV/EBITDA, TTM
- -10.42
Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.
AI analysis of Milestone Scientific Inc (MLSS)
holdMilestone Scientific Inc is not a strong buy right now due to mixed signals in financial performance and insider selling. The current price is $0.502, with a recent 5-day change of +4.41%, but the stock has a concerning insider selling increase of 2723.48%.
Analyst Ratings (1)
+99.20% upside
Buy
1 Buy
0 Hold
0 Sell
Current: 0.50
Low
1.00
Average
1.00
High
1.00
Benchmark
Speculative Buy
$1
2025-11-20
Benchmark
2025-11-20
Price Target
$1
Speculative Buy
Benchmark
Buy
$1.25
2024-11-20
Benchmark
2024-11-20
Price Target
$1.25
Buy
Benchmark
Buy
$1.25
2024-10-10
Benchmark
2024-10-10
Price Target
$1.25
Buy
Valuation Metrics
The current forward P/E ratio for Milestone Scientific Inc (MLSS) is 18.21, compared to its 5-year average forward P/E of -10.12.
Alphio AI Price Scenarios for MLSS
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
2.008-26NASDAQ.COMMilestone Scientific Eliminates Debt Through Equity Conversion
8.508-26NewsfilterMilestone Scientific Board Converts Debt to Equity
9.508-14Yahoo FinanceMilestone Scientific Reports Q2 2026 Earnings with Revenue Growth and Challenges
- 9.508-14Newsfilter
Medical Segment Revenue Grows 231% Year-Over-Year
8.508-07GlobenewswireMilestone Scientific Launches New Painless Injection Device
MLSS FAQ — answered by Alphio AI
Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).
Milestone Scientific Inc is not a strong buy right now due to mixed signals in financial performance and insider selling. The current price is $0.502, with a recent 5-day change of +4.41%, but the stock has a concerning insider selling increase of 2723.48%.
1 analysts cover MLSS: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 1.00.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.